Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Clinical Trials. Found 39 abstracts

no pagination
Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A, Ross E, Godwin A. Enhanced counselling for women undergoing BRCA 1/2 testing: Impact on knowledge and psychological distress-results from a randomised clinical trial. Psychology & Health. 2010 Jan;25(4):401-15.   PMCID: PMC2866521
Ozols RF. Treatment goals in ovarian cancer. International Journal of Gynecological Cancer. 2005 May;15 Suppl 1:3-11.
Langer CJ. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC. Int J Radiat Oncol Biol Phys. 2004 Mar;58(3):991-1002.
Langer CJ. CT-2103: a novel macromolecular taxane with potential advantages compared with conventional taxanes. Clinical lung cancer. 2004 Dec;6 Suppl 2:S85-8.
Eisenberg BL, von Mehren M. Pharmacotherapy of gastrointestinal stromal tumours. Expert Opin Pharmacother. 2003 Jun;4(6):869-74.
Langer C, Damsker J, Ridge A. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer. Clinical Advances in Hematology & Oncology. 2003 Jul;1(7):424-9, 440.
Ma GX, Fleisher L. Awareness of cancer information among Asian Americans. J Community Health. 2003 Apr;28(2):115-30.
Treat J. Weekly topotecan in the management of lung cancer. Lung Cancer. 2003 Aug;41 Suppl 4:S27-31.
Bookman MA. Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182). Semin Oncol. 2002 Feb;29(1 Suppl 1):20-31.
Hudes GR. Signaling inhibitors in the treatment of prostate cancer. Invest New Drugs. 2002 May;20(2):159-72.
Pollack A, Kuban DA, Zagars GK. Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer. Urology. 2002 Sep;60(3 Suppl 1):22-30; discussion 30-1.
Ajani J, Ettinger D, Kelsen DP, Hudis C, Kudelka A, Langer C, Pienta K, Safran H, Vokes EE, Yung WK. Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee. Int J Radiat Oncol Biol Phys. 2001 Jan;51(3 Suppl 2):88-91.
Burnett CB, Koczwara B, Pixley L, Blumenson LE, Hwang YT, Meropol NJ. Nurses' attitudes toward clinical trials at a comprehensive cancer center. Oncology Nursing Forum. 2001 Jan;28(7):1187-92.
Huang CH, Treat J. New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors. Oncology. 2001 Jan;61 Suppl 1:14-24.
Langer CJ. The emerging world role of irinotecan in lung cancer. Oncology (Huntingt). 2001 Jul;15(7 Suppl 8):15-21.
Langer CJ. The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer. Lung Cancer. 2001 Nov;34(2):297-303.
Ozols RF. The current role of gemcitabine in ovarian cancer. Semin Oncol. 2001 Apr;28(2 Suppl 7):18-24.
Sandler H, Shipley WU, Gomella L, Pienta K, Bard RH, Bruner D, Clark R, DeSilvio M, Gaspar L, Gillin M, Grignon D, Hammond E, Hanks G, Heydon KH, Kaufman DS, Lee WR, Michalski J, Mydlo J, Pisansky T, Pollack A, Porterfield H, Rifkin M, Roach M, Sanda M, True L, Vijayakumar S, Winter KA, Zeitman A. Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee. Int J Radiat Oncol Biol Phys. 2001 Jan;51(3 Suppl 2):28-38.
Scarantino C, Berk L, David F, Fisher J, Griffin P, Hartsell W, Konski A, Kuske R, Pilipich M, Scott C, Sperduto P. Radiation Therapy Oncology Group. Research Plan 2002-2006. Cancer Prevention and Control Committee. Int J Radiat Oncol Biol Phys. 2001 Jan;51(3 Suppl 2):113-9.
Segal DM, Weiner GJ, Weiner LM. Introduction: bispecific antibodies. J Immunol Methods. 2001 Feb;248(1-2):1-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Clinical Trials

Clinical Trials Human drug therapy administration & dosage therapeutic use Lung Neoplasms Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Non-Small-Cell Lung Carcinoma Male Prostatic Neoplasms Female Topotecan Organizational Objectives Treatment Outcome radiotherapy organization & administration Forecasting Survival Analysis Ovarian Neoplasms Professional Staff Committees Cisplatin analogs & derivatives Questionnaires Adjuvant Radiotherapy dt [Drug Therapy] Combined Modality Therapy Neoplasms Prognosis Head and Neck Neoplasms pathology mortality tu [Therapeutic Use] Deoxycytidine Research Design prevention & control Small Cell Carcinoma Paclitaxel therapy Non-US Gov't Support etiology antagonists & inhibitors drug effects Medical Oncology Neoplasm Staging 0 (Taxoids) Smoking Cessation drug Adult Protein Kinase C Age Factors Middle Age Health Education Camptothecin surgery Multivariate Analysis Nurse Attitudes Bivariate Statistics Leucovorin Multiple Regression Local Neoplasm Recurrence Polyglutamic Acid Data Collection use Piperazines Bladder Neoplasms Taxoids Cross-Sectional Studies Counseling Cancer Screening Palliative Care genetics Radiation Oncology Analysis of Variance therapeutic Radiotherapy Dosage Endpoint Determination Epidermal Growth Factor Receptor methods Adenocarcinoma US Gov't Support-PHS Oral Administration Japan Alkyl and Aryl Transferases Convenience Sample statistics & numerical data Quinazolines Attitudes Knowledge-Practice Neoplasm Drug Resistance Data Analysis Software Phytogenic Antineoplastic Agents New Jersey Drug Combinations Bispecific Antibodies Human Females United States drug effectsAdenocarcinoma ch [Chemistry] immunology Androgen Receptors Tegafur Androgen Antagonists Molecular Structure diagnosis Carboplatin 0 (Antineoplastic Combined Chemotherapy Protocols) Adjuvant Chemotherapy New York Health Knowledge T-Tests enzymology Quality of Life Distress Squamous Cell Carcinoma th [Therapy] Descriptive Research Phase III Clinical Trials Neoplasm Proteins pharmacology Gastrointestinal Neoplasms Doxorubicin Drug Synergism Disease-Free Survival Lymphatic Metastasis Funding Source Signal Transduction 0 (Antineoplastic Agents) trends Risk-Taking Etoposide Type I DNA Topoisomerases Confidence Intervals Radiation-Sensitizing Agents Use] Smoking Enzyme Inhibitors Interprofessional Relations Stromal Cells rt [Radiotherapy] ethnology Drug Administration Schedule pa [Pathology] Testing 25513-46-6 (Polyglutamic Acid) Animal Monoclonal Antibodies psychology Neoadjuvant Therapy tu [Therapeutic adverse effects
Last updated on Wednesday, August 12, 2020